Heron Therapeutics, Inc. · NASDAQ:HRTX

Rubric Capital Management LP reported a 15.90% stake in Heron Therapeutics, Inc. (Schedule 13D/A)

Event Oct 15, 2025 · Filed Oct 17, 2025

Rubric Capital Management LP reported a 15.90% stake in Heron Therapeutics, Inc., 30,046,828 shares, with active intent on Oct 15, 2025. Filed Oct 17, 2025 (Schedule 13D/A).

Stake
15.90%
Shares
30,046,828
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Rubric Capital Management LP15.90%30,046,828
David Rosen15.90%30,046,828

Source

View original at SEC

Related